0803mar 40
of 1
Transcript of 0803mar 40
-
8/14/2019 0803mar 40
1/1
Advertisement
40 AAPS NEWSMAGAZINE | MAR08
Europe, Asia, and USA enables ROQUETTE to develop
unctional excipients such as diluent-binders, granulation
binders, disintegrants, and flm coating polymers.
An in-house team o scientists is able to contribute to the
design o pharmaceutical ormulations and acilitate customers
developments, notably in the areas o:
Tablets obtained by direct compression or wet granulation
OTC and nutraceuticals as ber sources and mineral
supplements
Syrups, suspensions, Granules and sachets
Tablet Film coating and in-lm delivery systems
Toothpastes and mouthwashes
Injectables (enteral and parenteral solutions)
Focus on Innovation
Te demand or novel unctional excipients and health
supplements continues to grow steadily. Tanks to our
longstanding track record in excipients and actives innovation,
ROQUETTE is ready to meet this challenge:
NUTRIOSE soluble bers for nutraceutical formulations and
clinical enteral nutrition
NUTRALYS - a new natural, nonGMO, allergen free pea
protein
LYCOAT Novel starch-based polymers specically developed
or ast and simple aqueous flm coating. LYCATAB Mineral a compound developed for mineral
supplementation for nutraceutical and OTC applications
PEARLITOL mannitol as outstanding diluent-binder for
solid dosage orms
KLEPTOSE cyclodextrins for molecular encapsulation/
solubilization
Let us share our expertise with you to create outstanding new
ormulations!
Contact us: You can now gain immediate access to ROQUETTEs
extensive range o excipients and actives, as well as services
through our dedicated pharma website: www.roquettepharma.com. You can also contact us directly at the ollowing e-mail
address: [email protected].
ROQUETTE is a global manufacturer of pharmaceutical
excipients and actives. As a leading global partner
of the pharmaceutical industry, ROQUETTE has
been actively developing starch-based unctional
pharmaceutical excipients active ingredients and nutraceutical
ingredients to enable outstanding ormulations.
e U.S. FDA and European authorities regularly audit our
manuacturing acilities guaranteeing consistent compliance and
reliability of ROQUETTEs services and products to the highest
international quality requirements.
Leading Role in Injectables and Dialysis Solutions
ROQUETTE is the specialist of excipients for injectables and
dialysis solutions. Produced for over 20 years, pyrogen free
dextrose monohydrate LYCADEX PF is used by majority
o pharmaceutical companies involved in the production o
injectable solutions and inusions.
Te established range also includes pyrogen ree polyols
(PEARLITOL PF mannitol, NEOSORB PF sorbitol, and
XYLISORBPF xylitol) and KLEPTOSEHPB, pyrogen free
hydroxypropyl beta-cyclodextrin. Committed to providing the
most complete range o sae and reliable products or dialysis and
parenteral applications, ROQUETTE most recently introduced
pharma grade LACTATE and GLUCONATE salts.
Te Polyol World Leader
anks to its leadership in polyols, ROQUETTE oers the
broadest polyol excipient range providing excellent chemical
stability with good taste, sugar-ree sweetness and oral health
benefts or numerous pharmaceutical applications. Tis
includes:
PEARLITOL crystalline mannitol and granulated mannitol,
NEOSORB sorbitol,
MALTISORB maltitol,
XYLISORB xylitol and
LYCASIN maltitol syrups
Functional Excipients for Formulation Challenges
A dedicated manufacturing, research and QC network in
Roquette America, Inc.1417 Exchange Street
Keokuk, IA 52632
Tel 319-524-5757; 800-553-7035
www.roquettepharma.com
ROQUETTE PHARMA Making Life Better
